Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1997 2
1998 1
1999 1
2000 1
2001 3
2002 1
2003 2
2004 1
2005 4
2006 3
2007 1
2008 2
2009 4
2010 2
2011 4
2012 5
2013 11
2014 11
2015 11
2016 8
2017 6
2018 11
2019 11
2020 13
2021 23
2022 23
2023 19
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for daily hyun
Your search for Daeil Hyun retrieved no results
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O'Connor CM; VICTORIA Study Group. Armstrong PW, et al. N Engl J Med. 2020 May 14;382(20):1883-1893. doi: 10.1056/NEJMoa1915928. Epub 2020 Mar 28. N Engl J Med. 2020. PMID: 32222134 Free article. Clinical Trial.
METHODS: In this phase 3, randomized, double-blind, placebo-controlled trial, we assigned 5050 patients with chronic heart failure (New York Heart Association class II, III, or IV) and an ejection fraction of less than 45% to receive vericiguat (target dose, 10 mg once daily
METHODS: In this phase 3, randomized, double-blind, placebo-controlled trial, we assigned 5050 patients with chronic heart failure (New York …
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Participants were randomly assigned in a 1:1 ratio to receive sparsentan 400 mg once daily or irbesartan 300 mg once daily, stratified by estimated glomerular filtration rate at screening (30 to <60 mL/min per 1.73 m(2) and 60 mL/min per 1.73 m(2)) and urine prot …
Participants were randomly assigned in a 1:1 ratio to receive sparsentan 400 mg once daily or irbesartan 300 mg once daily, st …
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Patients aged 18 years or older with biopsy-proven primary IgA nephropathy and proteinuria of at least 1.0 g per day despite maximised renin-angiotensin system inhibition for at least 12 weeks were randomly assigned (1:1) to receive sparsentan (target dose 400 mg oral sparsentan …
Patients aged 18 years or older with biopsy-proven primary IgA nephropathy and proteinuria of at least 1.0 g per day despite maximised renin …
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.
Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ, Armstrong PW; VICTORIA Study Group. Lam CSP, et al. JAMA Cardiol. 2021 Jun 1;6(6):706-712. doi: 10.1001/jamacardio.2020.6455. JAMA Cardiol. 2021. PMID: 33185650 Free PMC article. Clinical Trial.
Data were analyzed between May 2, 2020, and May 9, 2020. INTERVENTION: Vericiguat titrated to 10 mg daily vs placebo. MAIN OUTCOMES AND MEASURES: The primary outcome was time to a composite of HFH or cardiovascular death; secondary outcomes were time to HFH, cardiovascular …
Data were analyzed between May 2, 2020, and May 9, 2020. INTERVENTION: Vericiguat titrated to 10 mg daily vs placebo. MAIN OUTCOMES A …
The Influence of Leisure Engagement on Daily Emotional Well-being.
Chen ST, Hyun J, Graefe AR, Mowen AJ, Almeida DM, Sliwinski MJ. Chen ST, et al. Leis Sci. 2022;44(7):995-1012. doi: 10.1080/01490400.2020.1757537. Epub 2020 Apr 27. Leis Sci. 2022. PMID: 37033273 Free PMC article.
The current study examined the associations between leisure engagement and daily emotional well-being, as measured by participants' mean levels of positive affect (PA), PA variability, and PA reactivity to stressors. ...However, multilevel models indicated that individuals …
The current study examined the associations between leisure engagement and daily emotional well-being, as measured by participants' m …
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, Kopeček M, Švancer P, Olmos I, Ricciardi C, Iglesias-Garcia C, Iglesias-Alonso A, Spina E, Ruan CJ, Wang CY, Wang G, Tang YL, Lin SK, Lane HY, Kim YS, Kim SH, Rajkumar AP, González-Esquivel DF, Jung-Cook H, Baptista T, Rohde C, Nielsen J, Verdoux H, Quiles C, Sanz EJ, De Las Cuevas C, Cohen D, Schulte PFJ, Ertuğrul A, Anıl Yağcıoğlu AE, Chopra N, McCollum B, Shelton C, Cotes RO, Kaithi AR, Kane JM, Farooq S, Ng CH, Bilbily J, Hiemke C, López-Jaramillo C, McGrane I, Lana F, Eap CB, Arrojo-Romero M, Rădulescu FŞ, Seifritz E, Every-Palmer S, Bousman CA, Bebawi E, Bhattacharya R, Kelly DL, Otsuka Y, Lazary J, Torres R, Yecora A, Motuca M, Chan SKW, Zolezzi M, Ouanes S, De Berardis D, Grover S, Procyshyn RM, Adebayo RA, Kirilochev OO, Soloviev A, Fountoulakis KN, Wilkowska A, Cubała WJ, Ayub M, Silva A, Bonelli RM, Villagrán-Moreno JM, Crespo-Facorro B, Temmingh H, Decloedt E, Pedro MR, Takeuchi H, Tsukahara M, Gründer G, Sagud M, Celofiga A, Ignjatovic Ristic D, Ortiz BB, Elkis H, Pacheco Palha AJ, LLerena A, Fernandez-Egea E, Siskind D, Weizman A, Masmoudi R, Mohd Saffian S, Leung JG, Buckley PF, Marder SR, Citro… See abstract for full author list ➔ de Leon J, et al. Pharmacopsychiatry. 2022 Mar;55(2):73-86. doi: 10.1055/a-1625-6388. Epub 2021 Dec 15. Pharmacopsychiatry. 2022. PMID: 34911124 Free article.
The Asian population (Pakistan to Japan) or the Americas' original inhabitants have lower CYP1A2 activity and require lower clozapine doses to reach concentrations of 350 ng/mL. In the US, daily doses of 300-600 mg/day are recommended. Slow personalized titration may preve …
The Asian population (Pakistan to Japan) or the Americas' original inhabitants have lower CYP1A2 activity and require lower clozapine doses …
Preclinical Voxel-Based Dosimetry in Theranostics: a Review.
Gupta A, Lee MS, Kim JH, Lee DS, Lee JS. Gupta A, et al. Nucl Med Mol Imaging. 2020 Apr;54(2):86-97. doi: 10.1007/s13139-020-00640-z. Epub 2020 Apr 19. Nucl Med Mol Imaging. 2020. PMID: 32377260 Free PMC article. Review.
Although MC simulation is considered to be an accurate method for voxel-based absorbed dose calculations, it is time-consuming, computationally demanding, and often impractical in daily practice. In this review, we focus on the current status of voxel-based dosimetry metho …
Although MC simulation is considered to be an accurate method for voxel-based absorbed dose calculations, it is time-consuming, computationa …
Complications Related to Transarterial Treatment of Hepatocellular Carcinoma: A Comprehensive Review.
Lee HN, Hyun D. Lee HN, et al. Korean J Radiol. 2023 Mar;24(3):204-223. doi: 10.3348/kjr.2022.0395. Epub 2023 Jan 19. Korean J Radiol. 2023. PMID: 36788765 Free PMC article. Review.
However, procedure-related complications have not been updated in the literature, although new types of transarterial treatments, such as drug-eluting bead transarterial chemoembolization and transarterial radioembolization, are common in daily practice. Herein, a comprehe …
However, procedure-related complications have not been updated in the literature, although new types of transarterial treatments, such as dr …
Reciprocal facilitation between mental and visuomotor rotations.
Guo J, Song JH. Guo J, et al. Sci Rep. 2023 Jan 16;13(1):825. doi: 10.1038/s41598-022-26397-3. Sci Rep. 2023. PMID: 36646722 Free PMC article.
Humans exhibit remarkably complex cognitive abilities and adaptive behavior in daily life. Cognitive operation in the "mental workspace," such as mentally rotating a piece of luggage to fit into fixed trunk space, helps us maintain and manipulate information on a moment-to …
Humans exhibit remarkably complex cognitive abilities and adaptive behavior in daily life. Cognitive operation in the "mental workspa …
Age-related enhancement in visuomotor learning by a dual-task.
Wang TSL, Martinez M, Festa EK, Heindel WC, Song JH. Wang TSL, et al. Sci Rep. 2022 Apr 5;12(1):5679. doi: 10.1038/s41598-022-09553-7. Sci Rep. 2022. PMID: 35383212 Free PMC article.
Many daily activities require performance of multiple tasks integrating cognitive and motor processes. ...
Many daily activities require performance of multiple tasks integrating cognitive and motor processes. ...
166 results